AAAAAA

   
Results: 1-8 |
Results: 8
TREATMENT AND PROPHYLAXIS OF DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEXIN HIV-INFECTED INDIVIDUALS
Authors: FARIS MA RAASCH RH HOPFER RL BUTTS JD
Citation: Ma. Faris et al., TREATMENT AND PROPHYLAXIS OF DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEXIN HIV-INFECTED INDIVIDUALS, The Annals of pharmacotherapy, 32(5), 1998, pp. 564-573
PHARMACOTHERAPY SPECIALTY CERTIFICATION EXAMINATION .5. FURTHER EXPERIENCE AND REFINEMENT
Authors: BOSSO JA STRINGER KA HAMMOND RW DIAZ DR HUTCHINSON RA MUNROE WP RAASCH RH SISCA TS SUMMERFIELD MR
Citation: Ja. Bosso et al., PHARMACOTHERAPY SPECIALTY CERTIFICATION EXAMINATION .5. FURTHER EXPERIENCE AND REFINEMENT, Pharmacotherapy, 17(2), 1997, pp. 399-406
LUMINAL EPIDERMAL GROWTH-FACTOR PRESERVES MUCOSAL MASS OF SMALL-BOWELIN FASTING RATS
Authors: ULSHEN MH RAASCH RH
Citation: Mh. Ulshen et Rh. Raasch, LUMINAL EPIDERMAL GROWTH-FACTOR PRESERVES MUCOSAL MASS OF SMALL-BOWELIN FASTING RATS, Clinical science, 90(5), 1996, pp. 427-431
PYRIMETHAMINE PHARMACOKINETICS IN HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE PATIENTS SEROPOSITIVE FOR TOXOPLASMA-GONDII
Authors: JACOBSON JM DAVIDIAN M RAINEY PM HAFNER R RAASCH RH LUFT BJ
Citation: Jm. Jacobson et al., PYRIMETHAMINE PHARMACOKINETICS IN HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE PATIENTS SEROPOSITIVE FOR TOXOPLASMA-GONDII, Antimicrobial agents and chemotherapy, 40(6), 1996, pp. 1360-1365
DISPOSITION OF DIDANOSINE IN HIV-SEROPOSITIVE PATIENTS WITH NORMAL RENAL-FUNCTION OR CHRONIC-RENAL-FAILURE - INFLUENCE OF HEMODIALYSIS AND CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
Authors: KNUPP CA HAK LJ COAKLEY DF FALK RJ WAGNER BE RAASCH RH VANDERHORST CM KAUL S BARBHAIYA RH DUKES GE
Citation: Ca. Knupp et al., DISPOSITION OF DIDANOSINE IN HIV-SEROPOSITIVE PATIENTS WITH NORMAL RENAL-FUNCTION OR CHRONIC-RENAL-FAILURE - INFLUENCE OF HEMODIALYSIS AND CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS, Clinical pharmacology and therapeutics, 60(5), 1996, pp. 535-542
PHARMACOKINETICS OF LAMIVUDINE ADMINISTERED ALONE AND WITH TRIMETHOPRIMSULFAMETHOXAZOLE
Authors: MOORE KHP YUEN GJ RAASCH RH ERON JJ MARTIN D MYDLOW PK HUSSEY EK
Citation: Khp. Moore et al., PHARMACOKINETICS OF LAMIVUDINE ADMINISTERED ALONE AND WITH TRIMETHOPRIMSULFAMETHOXAZOLE, Clinical pharmacology and therapeutics, 59(5), 1996, pp. 550-558
PHARMACOKINETICS AND BIOAVAILABILITY OF ZIDOVUDINE AND ITS GLUCURONIDATED METABOLITE IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND HEPATIC-DISEASE (AIDS CLINICAL-TRIALS GROUP PROTOCOL-062)
Authors: MOORE KHP RAASCH RH BROUWER KLR OPHEIM K CHEESEMAN SH EYSTER E LEMON SM VANDERHORST CM
Citation: Khp. Moore et al., PHARMACOKINETICS AND BIOAVAILABILITY OF ZIDOVUDINE AND ITS GLUCURONIDATED METABOLITE IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND HEPATIC-DISEASE (AIDS CLINICAL-TRIALS GROUP PROTOCOL-062), Antimicrobial agents and chemotherapy, 39(12), 1995, pp. 2732-2737
TICLOPIDINE AND ANTIPLATELET THERAPY
Authors: FLORESRUNK P RAASCH RH
Citation: P. Floresrunk et Rh. Raasch, TICLOPIDINE AND ANTIPLATELET THERAPY, The Annals of pharmacotherapy, 27(9), 1993, pp. 1090-1098
Risultati: 1-8 |